Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation

Clinical Infectious Diseases

Volumn 55, Issue 6, 2012, Pages 764-770

  Vydra, Jan ^a   Shanley, Ryan M ^b   George, Ige ^a   Ustun, Celalettin ^a   Smith, Angela R ^d   Weisdorf, Daniel J ^a   Young, Jo Anne H ^c  

^a Division of Hematology Oncology and Transplantation   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Department of Medicine   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VANCOMYCIN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HAZARD RATIO; HUMAN; INCIDENCE; INFANT; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; UNIVERSITY HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS INFECTION; VANCOMYCIN SENSITIVE ENTEROCOCCUS; VANCOMYCIN SENSITIVE ENTEROCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; MIDDLE AGED; MINNESOTA; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 84865457791     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis550     Document Type: Article

References (35)

1. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996-1011.
2. Koc Y, Snydman DR, Schenkein DS, Miller KB. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22:207-9. (Pubitemid 28375664)
3. Kirkpatrick BD, Harrington SM, Smith D, et al. An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin Infect Dis 1999; 29:1268-73. (Pubitemid 30265650)
4. Avery R, Kalaycio M, Pohlman B, et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 2005; 35:497-9. (Pubitemid 40403353)
5. Bossaer JB, Hall PD, Garrett-Mayer E. Incidence of vancomycinresistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2010; 19:231-7.
6. Kamboj M, Chung D, Seo SK, et al. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 2010; 16:1576-81.
7. Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect 2011; 18:1-7.
8. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-32. (Pubitemid 351763841)
9. Wolkewitz M, Vonberg RP, Grundmann H, et al. Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 2008; 12: R44.
10. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007; 26:2389-430. (Pubitemid 46730255)
11. Cox DR. Regression models and life tables. J R Stat Soc Series B 1972; 34:187-220.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
13. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997; 16:901-10. (Pubitemid 27198953)
14. Salgado CD. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. Am J Infect Control 2008; 36:S175.e5-8.
15. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995; 21:45-50.
16. Goetz AM, Rihs JD, Wagener MM, Muder RR. Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey. Am J Infect Control 1998; 26:558-62. (Pubitemid 28565071)
17. Chavers LS, Moser SA, Benjamin WH, et al. Vancomycin-resistant enterococci: 15 years and counting. J Hosp Infect 2003; 53:159-71. (Pubitemid 38002049)
18. European Centre for Disease Prevention and Control website. Available at: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/database/Pages/ database.aspx. Accessed 20 September 2011.
19. De Bruin MA, Riley LW. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis 2007; 7:24.
20. Weinstock DM, Conlon M, Iovino C, et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007; 13:615-21. (Pubitemid 46585935)
21. Zirakzadeh A, Gastineau DA, Mandrekar JN, Burke JP, Johnston PB, Patel R. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2008; 41:385-92. (Pubitemid 351330734)
22. Nourse C, Murphy H, Byrne C, et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr 1998; 157:20-7. (Pubitemid 28128096)
23. Huskins WC, Huckabee CM, O'Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011; 364:1407-18.
24. Almyroudis NG, Lesse AJ, Hahn T, et al. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol 2011; 32:490-6.
25. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycinsusceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005; 41:327.
26. DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005; 191:588-95. (Pubitemid 40216675)
27. McKinnell JA, Patel M, Shirley RM, Kunz DF, Moser SA, Baddley JW. Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents. Epidemiol Infect 2011; 139:1342-50.
28. Todeschini G, Tecchio C, Borghero C, et al. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies. Infection 2006; 53:266-73. (Pubitemid 44424268)
29. Theilacker C, Jonas D, Huebner J, Bertz H, Kern WV. Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak. Infection 2009; 37:540-3.
30. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996; 23:760-6. (Pubitemid 26331121)
31. Fernández Fernández FJ, De La Fuente Aguado J, Rubianes González M, et al. Enterococcus faecalis bacteremia. Rev Clin Esp 2004; 204:244-50. (Pubitemid 38744968)
32. Graninger W, Ragette R. Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. Clin Infect Dis 1992; 15:49-57.
33. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995; 20:296-301.
34. Suppola JP, Kuikka A, Vaara M, Valtonen VV. Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia. Scand J Infect Dis 1998; 30:153-7. (Pubitemid 28389073)
35. Chatterjee I, Dulhunty JM, Iredell J, et al. Predictors and outcome associated with an Enterococcus positive isolate during intensive care unit admission. Anaesth Intensive Care 2009; 37:976-82.